REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset - Yamashita, T; Kudo, M; Ikeda, K (J Gastroenterol, 2020)